SPC
MRNA icon

Sigma Planning Corp’s Moderna MRNA Stock Holding History

Sigma Planning Corp’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-25,705
Closed -$1.31M – 1454
2026
Q1 		$1.31M Sell
25,705
-5,056
-16% -$236K 0.04% 468
2025
Q4 		$907K Buy
+30,761
New +$836K 0.03% 569
2024
Q3 		– Sell
-1,939
Closed -$230K – 1255
2024
Q2 		$230K Sell
1,939
-1,374
-41% -$174K 0.01% 1028
2024
Q1 		$353K Buy
3,313
+536
+19% +$54K 0.01% 885
2023
Q4 		$276K Sell
2,777
-7,228
-72% -$608K 0.02% 653
2023
Q3 		$1.03M Sell
10,005
-1,528
-13% -$170K 0.04% 454
2023
Q2 		$1.4M Buy
11,533
+137
+1% +$18.3K 0.05% 363
2023
Q1 		$1.75M Sell
11,396
-671
-6% -$111K 0.06% 333
2022
Q4 		$2.17M Buy
12,067
+639
+6% +$104K 0.08% 267
2022
Q3 		$1.35M Sell
11,428
-89
-0.8% -$13.5K 0.05% 355
2022
Q2 		$1.65M Buy
11,517
+46
+0.4% +$6.58K 0.06% 315
2022
Q1 		$1.98M Sell
11,471
-549
-5% -$92.4K 0.06% 317
2021
Q4 		$3.05M Sell
12,020
-15,178
-56% -$4.44M 0.09% 239
2021
Q3 		$10.5M Buy
27,198
+13,973
+106% +$5.15M 0.31% 58
2021
Q2 		$3.11M Buy
13,225
+397
+3% +$70.9K 0.09% 238
2021
Q1 		$1.68M Sell
12,828
-408
-3% -$59.1K 0.05% 360
2020
Q4 		$1.38M Sell
13,236
-3,862
-23% -$391K 0.05% 363
2020
Q3 		$1.21M Sell
17,098
-1,015
-6% -$70.8K 0.05% 352
2020
Q2 		$1.16M Buy
18,113
+7,958
+78% +$436K 0.05% 348
2020
Q1 		$304K Buy
+10,155
New +$234K 0.02% 646

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Sigma Planning Corp's MRNA Position: Q2 2026 in Review

Sigma Planning Corp sold out of Moderna (MRNA) in Q2 2026, closing a stake of 25,705 shares — an estimated $1.31M sold.

Sigma Planning Corp first reported a position in MRNA in Q1 2020 and held it in 20 quarters. The position peaked at $10.5M in Q3 2021. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Sigma Planning Corp reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • Sigma Planning Corp sold 25,705 Moderna shares in Q2 2026, an estimated $1.31M.
  • Sigma Planning Corp first reported a position in Moderna in Q1 2020 and held it in 20 quarters.
  • Sigma Planning Corp's Moderna position peaked at $10.5M in Q3 2021.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Sigma Planning Corp's 13F filing for Q2 2026, filed 7 Aug 2026.